Recon: Eli Lilly to invest $27B in US drug manufacturing; India’s CDSCO to streamline export processes
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States